News in the Life Sciences Industry

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Jan. 13, 2020 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ( "Liminal BioSciences" or the "Company" ), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet... Read more ››

LAVAL, QC, Jan. 13, 2020 /CNW Telbec/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (Nasdaq: NEPT) (TSX: NEPT), a health and wellness company focused on extraction, purification and formulation of cannabinoids, would like to provide an update on its non-core investments.

OTTAWA, Jan. 13, 2020 /PRNewswire/ - Autonomous_ID Corporation said today that Denis R. Hebert has joined the Chairman's Advisory Board as a principal advisor on biometric identity and access-control systems. Hebert's appointment comes as the company pivots from research to real-world deployments... Read more ››

VANCOUVER, Jan. 10, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today confirmed that at its annual... Read more ››

LAVAL, QC, Jan. 10, 2020 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (Nasdaq: NEPT) (TSX: NEPT), a health and wellness company focused on extraction, purification and formulation of cannabinoids, would like to provide the following corporate updates and outlook... Read more ››

VANCOUVER, Jan. 10, 2020 /CNW/ - Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), announces that in conjunction with the January 10 and 11, 2020, Lift & Co Cannabis Expo in Vancouver Canada, Chemistree will unveil for our shareholders and... Read more ››

EDMONTON, Alberta, Jan. 10, 2020 /PRNewswire/ -- Tevosol, Inc., a clinical stage medical device company, and Texas Medical Center (TMC) Innovation, today announced that Tevosol has completed the TMCx accelerator program and established a base at TMC for FDA pivotal clinical trials and US commercial... Read more ››

Phagelux Will Update the Status of Its Product Pipeline

BOSTON and MONTRÉAL, Jan. 9, 2020 /PRNewswire/ - enGene Inc., the biotechnology company developing rationally designed gene therapies targeted... Read more ››